Presentamos hoy en #SER2025 dos estudios en Nefritis lúpica: 1️⃣ Impacto de fibrosis y atrofia tubular en desenlaces renales 2️⃣ Estudio multicéntrico de NL con triple terapia con belimumab 📊 ¡Seguimos avanzando! Soc.Esp.Reumatología Reumatologia Hospital Universitari de Bellvitge

¡Agradecida por recibir el Premio SER 2025 al mejor trabajo en #LupusEritematosoSistémico por nuestro artículo!🌟 Un honor este reconocimiento de la Soc.Esp.Reumatología a la investigación en #LES. Gracias a todos los coautores. Reumatologia Hospital Universitari de Bellvitge 🔗 Artículo: doi.org/10.1136/lupus-…

Nuestra R3 Dra Cubells presenta 26 casos de vasculitis reumatoide diagnosticados en H.Bellvitge. ⚠️ **Rara pero nunca olvidada**: Claves: neuropatía, úlceras, seropositividad, AR de larga evolución. #SER2025 Soc.Esp.Reumatología

Ganadores del Reumatrivial!! Gran equipo!! 🔝

Miocarditis lúpica: Complicación potencialmente fatal y frecuentemente infradiagnosticada en nuestros pacientes con Lupus. Presentamos la evolución y tratamientos de nuestra serie de casos:

The 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus (SLE) #SLE #Lupus #Rheumatology #MedTwitter👇

16th International Congress on SLE Lupus 2025 Beatriz Frade Sosa Paola Vidal Montal Jorge Fragío | Rheumatology Roxana González

Lupus Nephritis & Fibrosis Hypoxia in tubular epithelial cells induces ADAM9 via HIF-1α ➡️activates TGF-β1 ➡️drives fibrosis in lupus nephritis 💡Targeting hypoxia-induced ADAM9 could limit renal damage and chronic progression in LN #LUPUS2025

In LN, IFN signatures stratify therapeutic responses: 🔹Low IFN: respond to mTORi, calcineurin & TK inhibitors 🔹Intermediate: anti-CD19, CD38, BTK 🔹High IFN: benefit from anti-IFNAR, anti-CD22, anti-CD38 #LUPUS2025 Ioannis Parodis pubmed.ncbi.nlm.nih.gov/38899167/

Diagnóstico a tener en cuenta como mimiker de múltiples enfermedades reumáticas! #whipple Letter to the editor de Dra De Daniel R4 de Reumatologia Hospital Universitari de Bellvitge

🎤 Presenting our multicentre study on lupus nephritis today at #LUPUS2025 ! Excited to share key findings & collaborate with experts in the field. Grateful to our team & partners for making this research possible. Reumatologia Hospital Universitari de Bellvitge Irene Altabás Beatriz Frade Sosa José A. Gómez Puerta Lupus 2025

Congrats Paola Vidal Montal RWD about LN patients treated with combined therapy (Belimumab + IS). New data coming soon!

Great having participated in this interesting work by Beatriz Frade Sosa José A. Gómez Puerta Irene Altabás . Much more to come! #LUPUS2025

Last day at Lupus 2025 #LUPUS2025 with this great spanish team!! Soc.Esp.Reumatología

#EULAR2025 EULAR update #Recommendations #Rheumatoid #Rx prof Smolen subtle diff between former guidelines MTX+GC 👇 D/C GCs rapidly 👇 If inadequate response 👇 Other csDMARDs are OUT ❎ ✅go to bDMARD or tsDMARD* TsDMARD after safety assessed Dr. John Cush RecommendatnII

Congratulations to our R4 Dra Roig Kim for presenting today in a poster tour at #EULAR2025! She shared important data on fracture incidence in RA patients treated with rituximab—great contribution to real-world evidence. #RA #EULAR2025

Dr Aguilar presented insightful work on remote clinical management of patients with lupus at #EULAR2025—can it help predict stable disease? A project developed during his external rotation in Oxford with Dr Luqmani. #SLE #Telemedicine #Rheumatology

🧬 Avui 23/07 és el Dia Mundial del Sjögren, i des de l'Societat Catalana de Reumatologia ens sumem a la seva visibilització! És tracta d'una malaltia autoimmune que pot provocar sequedat ocular i bucal, cansament i altres símptomes👁️💧 💊 L’estil de vida és clau per millorar la qualitat de vida!

Great news for Sjogren disease!!

Our study on atypical organ involvement in giant cell arteritis has just been published !! 📊 Nearly 1 in 3 patients presented non-classical manifestations, sometimes as the first sign. Early recognition is key to preventing complications sciencedirect.com/science/articl…